Adaptive Biotechnologies (ADPT) EPS (Basic) Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) EPS (Basic) Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 10.33% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -6.31% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 16.67% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 5.62% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -3.09% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 21.11% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 43.02% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 5.89% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.55% |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn | 5.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.36% |
| Dec 31, 2025 | 29.61% |
| Sep 30, 2025 | 29.73% |
| Jun 30, 2025 | -20.35% |
| Mar 31, 2025 | 48.55% |
| Dec 31, 2024 | 22.71% |
| Sep 30, 2024 | 51.83% |
| Jun 30, 2024 | 49.90% |
| Mar 31, 2024 | 49.62% |
| Dec 31, 2023 | -12.31% |
| Sep 30, 2023 | -8.37% |
| Jun 30, 2023 | -7.94% |
| Mar 31, 2023 | -17.30% |
| Dec 31, 2022 | 2.90% |
| Sep 30, 2022 | -44.94% |
| Jun 30, 2022 | 27.75% |
| Mar 31, 2022 | -0.60% |
| Dec 31, 2021 | 24.07% |
| Sep 30, 2021 | -43.60% |
| Jun 30, 2021 | -35.22% |